The Trial Did Not Meet the Primary Endpoint of Progression-Free Survival (PFS) – – A Trend Favoring the Selinexor Arm was Observed with a 5.3 Month Improvement in Median PFS Relative to the Placebo ...
One of the most memorable aspects of visiting Wolf Haven International is the possibility of hearing wolves howl. This isn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results